Real-time enrollment status for this recurrent group 3 medulloblastoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:16 AM UTC
| NCT Number | NCT06514898 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Group 3 Medulloblastoma |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 17, 2026: Clinical trial NCT06514898 is currently recruiting participants. This phase1 study for recurrent group 3 medulloblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06514898 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06514898 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.